dúlaglútíð - search results

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

trulicity solution for injection

eli lilly and company - dulaglutide - solution for injection - 1,5mg/0.5ml

Singapore - English - HSA (Health Sciences Authority)

trulicity injection 0.75mg0.5ml

dksh singapore pte. ltd. - dulaglutide - injection, solution - dulaglutide 0.75mg/0.5ml

Singapore - English - HSA (Health Sciences Authority)

trulicity injection 1.5mg0.5ml

dksh singapore pte. ltd. - dulaglutide - injection, solution - dulaglutide 1.5mg/0.5ml

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

trulicity 1.5mg solution for injection in pre-filled pen

zuellig pharma sdn bhd - dulaglutide -

New Zealand - English - Medsafe (Medicines Safety Authority)

trulicity

eli lilly and company (nz) limited - dulaglutide 3 mg/ml - solution for injection - 1.5 mg/0.5ml - active: dulaglutide 3 mg/ml excipient: citric acid mannitol polysorbate 80 sodium citrate dihydrate water for injection - type 2 diabetes mellitus: glycaemic control: trulicity is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus: o as monotherapy. o in combination with other glucose-lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control (see section 5.1 for data with respect to different combinations). type 2 diabetes mellitus: reduction in risk of major adverse cardiovascular events: trulicity is indicated as an adjunct to standard of care therapy to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus who have: o established cardiovascular disease or o multiple cardiovascular risk factors